Ignore these popular cannabis stocks and buy the only Canadian grower that's managed to deliver a no-nonsense profit.
The cannabis industry will be breaking down a number of new barriers next year.
A holding period of forever sounds perfect for these top-tier businesses.
It's probably a smaller number than you thought.
The days of smooth sailing for cannabis stocks have come to an abrupt end.
This should help to relieve a lot of worries about America's most successful social program.
Marijuana reform measures could stall in the Oval Office if any of these presidential hopefuls wins in 2020.
These pot stocks are handily outselling two of the most popular names in cannabis.
Being patient will net you more than just a large monthly payout.
The Food and Drug Administration's consumer update on cannabidiol might appear damning, but investors can still profit from CBD's growth.
These cannabis stocks are liable to be buzzkill for years to come.
Stop blaming baby boomers for being born. There are far bigger problems at work behind the scenes.
Don't be fooled by their lofty forward price-to-earnings ratios -- these companies are actually a great value.
Marijuana stock market caps continue to shrink.
Multistate dispensary operators have a new tool in their arsenal to raise cash.
These cannabis pure-plays all gained at least 10% in an otherwise awful month for pot stocks.
Valued at just three times fiscal 2021 sales, is cannabis stock HEXO a screaming buy or a value trap?
Though the stock market offers no guarantees, the pendulum appears to heavily favor long-term investors profiting from this dominant company.
There's not a more profitable pot stock on the planet right now.
Unfortunately, popularity offers no guarantee of profitability.